Key Findings from the DapaTAVI Trial
Dapagliflozin Reduces Heart Failure Risk After TAVI: Key Findings from the DapaTAVI Trial We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
